Whittier Trust’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-115
Closed -$4.14K 1562
2024
Q4
$4.14K Hold
115
﹤0.01% 1391
2024
Q3
$4.88K Hold
115
﹤0.01% 1377
2024
Q2
$4.63K Buy
+115
New +$4.8K ﹤0.01% 1350
2023
Q4
Sell
-17
Closed -$353 1669
2023
Q3
$353 Buy
+17
New +$467 ﹤0.01% 1599
2023
Q1
Sell
-3,000
Closed -$135K 1638
2022
Q4
$135K Buy
+3,000
New +$136K ﹤0.01% 739
2022
Q2
Sell
-15
Closed -$2K 1771
2022
Q1
$2K Buy
+15
New +$1.75K ﹤0.01% 1609

Other funds holding TNDM

Whittier Trust's TNDM Position: Q1 2025 in Review

Whittier Trust sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 115 shares — an estimated $4.14K sold.

Whittier Trust first reported a position in TNDM in Q1 2022 and held it in 6 quarters. The position peaked at $135K in Q4 2022. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Whittier Trust reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Whittier Trust sold 115 Tandem Diabetes Care shares in Q1 2025, an estimated $4.14K.
  • Whittier Trust first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 6 quarters.
  • Whittier Trust's Tandem Diabetes Care position peaked at $135K in Q4 2022.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Whittier Trust's 13F filing for Q1 2025, filed 2 May 2025.